How L’Occitane’s Dr Vranjes Firenze aims to grow in Australia and beyond
Inside Retail
FEBRUARY 25, 2024
L’Occitane purchased Dr Vranjes Firenze in January this year for a reported US$164 million, or approximately 12 times its core earnings, from Bluegum Capital Partners, a European private equity fund that specialises in consumer brands. L’Occitane also acquired a 50 per cent stake in Singaporean skincare brand Erborian in 2012.
130 
Let's personalize your content